Literature DB >> 23174904

BCR-ABL mediated repression of miR-223 results in the activation of MEF2C and PTBP2 in chronic myeloid leukemia.

S Agatheeswaran, S Singh, S Biswas, G Biswas, N Chandra Pattnayak, S Chakraborty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23174904     DOI： 10.1038/leu.2012.339

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  Nanoparticle delivery of miR-223 to attenuate macrophage fusion.

Authors:  Laura Beth Moore; Andrew J Sawyer; Jennifer Saucier-Sawyer; W Mark Saltzman; Themis R Kyriakides
Journal:  Biomaterials       Date:  2016-02-26       Impact factor: 12.479

2.  Targeting the SMO oncogene by miR-326 inhibits glioma biological behaviors and stemness.

Authors:  Wenzhong Du; Xing Liu; Lingchao Chen; Zhijin Dou; Xuhui Lei; Liang Chang; Jinquan Cai; Yuqiong Cui; Dongbo Yang; Ying Sun; Yongli Li; Chuanlu Jiang
Journal:  Neuro Oncol       Date:  2014-08-30       Impact factor: 12.300

3.  Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivo.

Authors:  Yusuke Tarumoto; Shan Lin; Jinhua Wang; Joseph P Milazzo; Yali Xu; Bin Lu; Zhaolin Yang; Yiliang Wei; Sofya Polyanskaya; Mark Wunderlich; Nathanael S Gray; Kimberly Stegmaier; Christopher R Vakoc
Journal:  Blood       Date:  2020-01-02       Impact factor: 25.476

4.  miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions.

Authors:  Eva Maria Pinatel; Francesca Orso; Elisa Penna; Daniela Cimino; Angela Rita Elia; Paola Circosta; Patrizia Dentelli; Maria Felice Brizzi; Paolo Provero; Daniela Taverna
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

Review 5.  The Role of MicroRNAs in Myeloproliferative Neoplasia.

Authors:  Shaban Alizadeh; Seyed Ghader Azizi; Masoud Soleimani; Yadollah Farshi; Zahra Kashani Khatib
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-07-01

6.  Functional Screening Identifies MicroRNAs as Multi-Cellular Regulators of Heart Failure.

Authors:  Robin Verjans; Wouter J A Derks; Kerstin Korn; Birte Sönnichsen; Rick E W van Leeuwen; Blanche Schroen; Marc van Bilsen; Stephane Heymans
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

7.  Downregulation of miR-142a Contributes to the Enhanced Anti-Apoptotic Ability of Murine Chronic Myelogenous Leukemia Cells.

Authors:  Zhiwei Chen; Yinyin Xie; Dan Liu; Ping Liu; Fei Li; Zhanglin Zhang; Mengmeng Zhang; Xiaolin Wang; Yuanliang Zhang; Xiaojian Sun; Qiuhua Huang
Journal:  Front Oncol       Date:  2021-07-27       Impact factor: 6.244

8.  Methylation‑associated silencing of miR‑638 promotes endometrial carcinoma progression by targeting MEF2C.

Authors:  Jianjiao Ni; Shanhui Liang; Boer Shan; Wenjuan Tian; Huaying Wang; Yulan Ren
Journal:  Int J Mol Med       Date:  2020-03-16       Impact factor: 4.101

Review 9.  The many facets of miR-223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response.

Authors:  Andrea Favero; Ilenia Segatto; Tiziana Perin; Barbara Belletti
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-05-05       Impact factor: 9.957

10.  A Systematic Review of Candidate miRNAs, Its Targeted Genes and Pathways in Chronic Myeloid Leukemia-An Integrated Bioinformatical Analysis.

Authors:  Marjanu Hikmah Elias; Syarifah Faezah Syed Mohamad; Nazefah Abdul Hamid
Journal:  Front Oncol       Date:  2022-03-07       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.